Document is current
Any future updates will be listed below
-
Authors
Lim, Mandy Yu Theng https://orcid.org/0009-0002-9627-9423
Tan, Chermaine
Subhramanyam, Charannya Sozheesvari
Teo, Shi Jie
DeFalco, Louis https://orcid.org/0000-0003-1874-1838
Pasaribu, Samuel Kevin
Koh, Chong Hui
Rayamajhi, Dheeraj
Chi, Jieying https://orcid.org/0009-0008-3094-2628
Li, Shengnan
Wee, Keng Boon
Roy, Sudipto
Huber, Roland G. https://orcid.org/0000-0001-5093-5988
Aw, Sherry Shiying https://orcid.org/0000-0003-3067-0323
-
Funding
Funding for this research was provided by:
Agency for Science, Technology and Research (H20C6a0034)
Agency for Science, Technology and Research (UIBR)
Agency for Science, Technology and Research (Cell and Gene Therapy Flagship Grant C253623010)
Agency for Science, Technology and Research (IAF-PP H20C6a0034)
MOH | National Medical Research Council (OFYIRG16may045)
A*STAR | Institute of Molecular and Cell Biology (Core funding)
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 22 December 2025
First Online: 10 January 2026
Competing interests
: S.S.A., M.L., C.T., C.S.S., S.J.T., S.K.P. and C.H.K. are inventors on patent applications related to the ribozymes described in this paper. The remaining authors declare no competing interests.
